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The purpose of this study was to evaluate the sonographic features of thyroid nodules suspicious for
malignancy with standard examination in B-mode and Color Doppler associated with modern tech-
niques such as ultrasound RTE (Real Time Elastosonography) and BFI (B-ﬂow imaging) in correlation with
the results of the sonographically guided ﬁne-needle aspiration to establish their role in predicting the
risk of malignancy.
Between November 2012 and January 2014, 354 consecutive patients (age range, 18e73 years; mean
age ± SD, 41.2 ± 9.2 years; 90 male and 264 female) with 493 suspected nodules (maximum
diameter > 9 mm) were enrolled in this prospective study.
Sonographic, elastosonographic and BFI examinations were performed with a commercially available
real-time ultrasound system, and all patients also underwent a cytologic evaluation. Patients with sus-
picious or malignant cytologic features underwent surgery.
On histologic examination, 71 of 493 nodules were malignant (62 papillary thyroid carcinoma, 1
Hürthle cell carcinoma, and 8 follicular carcinoma). All sonographic characteristics, which were potential
predictors of thyroid malignancy (microcalciﬁcations, hypoechogenicity, absence of a halo, and a pre-
dominantly solid composition), were found in different percentages in both histologically veriﬁed ma-
lignant and benign nodules. For BFI, pattern 3 (4 signs and distance > 2 mm) was the most predictive
factor for malignancy (speciﬁcity, 99.6%; sensitivity, 65.2%), whereas pattern 2 (4 signs and
distance < 2 mm) was a positive factor because it was detected only in benign lesions. For the RTE, scores
1e2 were detected in 68% of benign nodules, while scores 3e4 in 94% of malignant nodules.
Our results indicate that Elastosonography and BFI can overcome the limits of the traditional B-mode
and color Doppler sonographic features in the diagnosis of thyroid nodules. This techniques provides
maximum speciﬁcity levels both in the case of benign nodules and in the case of malignant nodules.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Thyroid nodules are the most common endocrine cancer,
affecting more than 50% of women over 50 years of age. Screening
studies based on general population identify clinically palpable
nodules in approximately 5% of adults, while ultrasound and au-
topsy studies have demonstrated nodules in more than 50% of
women and 20% of men over the age of 50, [1]. Thyroid cancer,inelli).
by Elsevier Ltd. All rights reservedwhich usually presents as a nodule, is increasing in incidence faster
than any other cancer, however, it is thought that this increase is
due to an improvement in the incidence of technical study of the
thyroid as well as the use of screening policies on population [2].
However, only less than 5% of all nodules identiﬁed, regardless of
their size, both by palpation is discovered purely incidental, direct
the investigation appears malicious.
The primary challenge in the evaluation of thyroid nodules is
reliably identify the majority of benign nodules that do not require,
therefore, surgical removal, avoiding the risk of not identifying
malignant nodules (or pre e malignant) and thus losing the pos-
sibility of a treatment early surgical effectively also because.
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ﬁcacy in the case of thyroid cancer as well as of othermore common
solid tumors [3].
The number of FNA procedures continues to growat a rapid pace
and may be partly responsible for the increasing incidence of
cancer diagnosis [4e8]. With the increasing use of imaging tech-
nologies that identify thyroid nodules, including the use of ultra-
sound as screening tool in the general population, the cost and
morbidity of the evaluation of thyroid nodules is likely to become a
problem for the public health expenditure, therefore, a convenient
and effective strategy for the evaluation of these nodules is an
important objective for current and future applications in clinical
practice [9e12].
For the study of nodular thyroid disease recourse is the use of
ultrasound, not only understood as a morphological study in B-
mode, in which we evaluate the structural characteristics of
nodulation, but also with the use of new techniques such as ul-
trasound Color Doppler, for the evaluation of the vascularity of the
B-flow imaging, which as we will see below is able to give us
important information on the nature of the nodule, and ﬁnally with
the use of recent elastosonography. The integrated ultrasound ex-
amination, then, will, once identiﬁed a nodule, to tell if that
nodulation can be considered benign, suspicious for malignancy or
frankly malignant. However, beyond this end, ultrasound also has
the role of responding to the questions of the surgeon who later
proceed to intervention, we must determine whether the individ-
ual is suspected of nodulation or less, the characteristics of malig-
nancy, but the seat even if there is an involvement of lymph nodes,
stations latero- cervical superﬁcial and deep, because this element
must be to affect the type and extent of surgery.
2. Methods
Between November 2012 and January 2014, 354 consecutive
patients (age range, 18e73 years; mean age ± SD, 41.2 ± 9.2 years;
90 male and 264 female) with 493 suspected nodules (maximum
diameter >9 mm) were enrolled in this prospective study. The
patients' main characteristics were palpable and nonpalpable thy-
roid nodules.
After the sonographic examinations, we selected 343 patients
with 493 suspected nodules to execute an FNA cytologic evaluation
according to selection criteria of the 2005 ultrasound consensus
conference statement of the Society of Radiologists in Ultrasound
[14]. Thyroid hormone serum levels, thyroid-stimulating hormone
levels, and calcitonin levels were normal in all patients. The study
was conducted according to the principles of the Declaration of
Helsinki. Written informed consent was obtained from all patients.
Methods Sonographic, Color Doppler (CD), and BFI examinations
were performed with a LOGIQ 9 system (GE Healthcare, Chalfont St
Giles, England), a commercially available real-time sonography
system, equipped with 5- to 14-MHz (M12L) and 2.5- to 7-MHz (7L)
linear array transducers. All examinations were performed by 2
blinded radiologists separately, and all data analysis was performed
by another investigator. When results of the examiners were
discordant, agreement was found by a conjoint review of clips from
the sonographic examinations.
The following sonographic characteristics were recorded for
each nodule: size, parenchymal composition, echogenicity, pres-
ence or absence of a halo, margin characteristics, and presence or
absence of microcalciﬁcations. As to the size, 3 orthogonal di-
mensions were measured. The echogenicity of each nodule was
determined by comparing the solid portion of the nodule to the
surrounding thyroid parenchyma. Echogenicity was rated as
hyperechoic when more echogenic, isoechoic when similar, or
hypoechoic when less echogenic than the thyroid tissue [6].Hyperechoic spots (calciﬁcations or colloidal crystals) were
assessed by taking into account the surrounding thyroid tissue.
[5],14 In this study, CFD analysis was performed at 7.5 MHz (M12L)
and 6 MHz (7L) to evaluate the presence of marked intranodular
blood ﬂow.15 B-ﬂow imaging was performed at 10MHz (M12L) and
7 MHz (7L) with the BFI capability at the level of the nodule. The
pulse repetition interval was set at 3. The BFI gainwas not ﬁxed and
was adjusted to allow better visualization of the signs. This tech-
nique focuses on high ﬂowwith suppression of the tissue signal. B-
ﬂow images were used to evaluate the presence, appearance, in-
tensity, and distribution of the signs (grouped or scattered within
the nodule).
For the classiﬁcation, the single scan in which the greatest
number of signs was visible was selected, and quantiﬁcation of
signs was assessed for each scan. In case of 4 or more signs, the
minimum distance among themwas measured. The distances were
manually measured with the cursor on the image with the highest
number of twinkling signs. The sign distribution in a single scan
(the maximum number of signs inside the nodule evaluated in a
single scan) followed 4 patterns, which were classiﬁed as follows:
pattern 0, absence of signs; pattern 1, fewer than 4 signs; pattern 2,
4 ormore signs and a distance of less than 2mm; and pattern 3, 4 or
more signs and a distance of greater than 2 mm.
Later was carried out the study elastosonography of suspicious
nodules. Elastosonography is a technique that evaluates the degree
of compressibility of a tissue, and then evaluates mechanical
properties of tissues. The deformation of the structures was ach-
ieved with the mechanical compression given by the probe. During
the exam, the system calculates the levels of tissue deformation and
displays them as green and gray on the side of the image. The bar
indicates an appropriate (green) or inadequate (gray) tissue
deformation in order to obtain a good quality of elastosonographic
evaluation. The display mode “dual” allows you to view the elas-
tosonographic image and the corresponding B-mode image, at the
same time. In our experience, the box of interest is selected to
include the nodule and part of the surrounding parenchyma;
sampling was carried out before entering a region of interest (ROI)
on the nodule in question and a second ROI above the adjacent
parenchyma. In our study, the images obtained were classiﬁed into
four scales of stiffness to decrease the degree of elasticity:
 1: nodule evenly colored in light green.
 2: the central part of the nodule in the periphery in green and
blue.
 3: nodule colored with a mixture of green and red.
 4: nodule completely colored in blue.
Nodules with a score of 1 and 2 were classiﬁed as probably
benign nodules while scoring 3 and 4 as probably malignant. This
classiﬁcation was compared with the cytological diagnosis in order
to evaluate the sensitivity and speciﬁcity of the RTE. In addition to
evaluation based on the color, the value of ratio distortion (SR; M1/
M2) was quantiﬁed for each nodule, SR was calculated by the
average value of stiffness measured in ROIe 1 corresponding to the
nodule and indicated byM1 and average value for the ROI 2, located
at the level of the surrounding parenchyma and indicated with M2.
A value of SR C 3:28 was considered indicative of malignancy.
The same ultrasound techniques were then applied to the study
of the lateral cervical lymph node stations to assess and describe
the lymph node involvement in cases of thyroid malignancy. Even
in this case after a morphological evaluation based on the structural
characteristics of the lymph node and that is: the round shape
(ratio of short axis to long axis of >0.5), the absence of hyperechoic
hilum, abnormal echogenicity, presence of calciﬁcations, the vari-
ation in sense of cystic and/or abnormal vascularity, with loss of
Table 1
Sensitivity, Speciﬁcity of US standard.
Speciﬁcity (%) Sensitivity (%) PPV (%) NPV (%)
Irregular margins or
absence of halo
73 43 21 87
Microcalciﬁcations 96 35 52 91
Hypoechogenicity 53 64 17 90
Intranodular color
Doppler ﬂow
80 57 31 92
Table 2
Sensitivity, Speciﬁcity and PPV in detecting malignant nodules.
Sensitivity (%) Speciﬁcity (%) PPV (%)
US 75 94 94
FNAB 98 28 59
B-Flow (pattern 3) 99 66 95
RTE 94 68 32
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tion in B-ﬂow where they were evaluated in the same way the
presence or absence of signals, indicative of the presence of
microcalciﬁcations lymph node that correlate with metastatic
papillary thyroid carcinoma and ﬁnallywas also associatedwith the
elastosonographic evaluation lymph nodes whose degree of rigid-
ity, evaluated against adiposity surrounding, elastosonography
classiﬁed into four categories.
After the sonographic features were assessed, patients under-
went a cytologic evaluation, and ﬁndings were recorded by a
radiologist. Sonographically guided FNA was simultaneously per-
formed by two radiologists. The physicians were extremely expe-
rienced in performance of sonographically guided FNAwith 27- and
22-gauge needles; the technique used has been described in the
literature. Three or 4 smears were prepared; the ﬁrst was air dried
and immediately stained with Diff-Quik (Baxter Scientiﬁc, McGraw
Park, IL), which is a May-Grünwald-Giemsa modiﬁed stain that
allows staining of smears in less than 1 min. The other smears were
ﬁxed in absolute alcohol for a subsequent Papanicolaou test or
immunostains The Diff-Quik smears were immediately evaluated
by a cytopathologist to assess the adequacy of the samples. Inad-
equate smears were immediately repeated. Cytologically benign
cases were enrolled for a clinical and sonographic follow-up to
control the dimensions and sonographic features of the nodules.
Patients with suspicious ormalignant cytologic features underwent
surgery with an additional intraoperative frozen section examina-
tion, which conﬁrmed the cytologic diagnosis. To improve accuracy
levels, cytospray ﬁxation of frozen intraoperative sections was
used, and comparative observation of cytologic imprints was per-
formed. All of the patients underwent a total thyroidectomy with
cervical node exploration. Ipsilateral central neck lymph node
dissection was performed in patients with suspicious nodal
enlargement. Removal of lateral neck nodes was performed in cases
of conﬁrmed nodal metastases at the frozen section examination.
Surgical samples were cut before ﬁxation for macroscopic exami-
nation. Histologic evaluation was performed on multiple 5-mm
slices of the whole thyroid gland to estimate the tumor di-
mensions and to rule out malignant and multifocal lesions. Speci-
mens were then routinely processed; tumors were diagnosed and
staged on the basis of their size, nodal involvement, and distant
metastasis (TNM) according to the current classiﬁcation criteria. A
statistical evaluation was performed with the c2 test and the pre-
dictivity test.
After, we examined for preoperative sonographic evaluation
with gray-scale ultrasonography (US), color Doppler US, BFI-TS and
elastosonography. 157 patients with suspicious metastatic cervical
LN at US examination underwent FNAB for cytology and thyro-
globulin determination in the aspirate ﬂuid. Only 109 patients (38
men, 71 women; mean age 54 years range, 25e77 years) with at
least one metastatic LN were included in our study. All these pa-
tients underwent surgery, and the ﬁnal diagnosis was based on the
results of histologic examination of the resected specimens.
3. Results
The speciﬁcity, sensitivity, positive predictive value (PPV), and
negative predictive value (NPV) of the different sonographic fea-
tures of malignancy are summarized in Table 1. The following
sonographic features were taken into account: absence of a halo or
irregular margins, microcalciﬁcations, hypoechogenicity, and
intranodular vascularization (Table 1).
Among each single sonographic pattern, the presence of
microcalciﬁcations was the most predictive factor of malignancy
(Table 1; P < .001; speciﬁcity, 96%; sensitivity, 35%). Absent halo
signs or irregular margins were found in 31 of 71 malignant lesionsand also in 118 of 422 benign nodules (not statistically signiﬁcant).
Hypoechogenicity was found in 46 of 71 malignant lesions and in
203 of 422 benign nodules (not statistically signiﬁcant). Intra-
nodular color Doppler ﬂow CFDwas also one of the most predictive
factors of malignancy (Table 1; P < .001; speciﬁcity, 80%; sensitivity,
57%). B-Flow Imaging Evaluation Pattern 3 was the most predictive
factor of malignancy (P < .001; speciﬁcity, 99%; sensitivity, 66%;
PPV, 95%; NPV, 91%). On histologic evaluation, 45 of 47 nodules
(96%) showing this pattern resulted in PTC, whereas 2 of 47 nodules
(4%) resulted in benign lesions. When present, pattern 2 was a
positive factor because it was detected only in benign lesions, with
a PPV of 0. Pattern 1 was present in 6 of 71 tumors and in 50 of 422
benign lesions (not statistically signiﬁcant). Pattern 0 had low
sensitivity (26%) and speciﬁcity (48%). Fifty-one of 62 PTC nodules
were positive for the BFI twinkling sign; 46 showed pattern 3, and 5
were characterized as pattern 1. Only 11 of 62 PTC nodules did not
show the sign (pattern 0). The other 9 malignant nodules with
pattern 0 showed different histologic types .
Elastosonography with evaluation of the color map yielded the
following:
Scores 1e2were detected in 68% of benign nodules, while scores
3e4 in 94% of malignant nodules. The distribution of the SS (stiff-
ness score) according to the cytological categories of diagnosis. SS
values were higher in nodules with a diagnosis of malignancy than
in benign nodules. The qualitative RTE analysis based on the SS had
a 94% sensitivity, 68% speciﬁcity, 32% PPV (Table 2).
A total of 773 LNs were analyzed. Of these, 341 were metastatic
while the remaining 432 were benign, as evaluated by histopa-
thology. The diagnostic performance of each ultrasound ﬁnding
evaluated in this study is shown in Table. Most ultrasound features
had high speciﬁcity and positive predictive value (PPV) but low
sensitivity and negative predictive value (NPV). The sonographic
characteristic with high speciﬁcity and sensitivity were the BFI-TS
and elastosonography. The BFI-TS was positive in all LNs with
microcalciﬁcations at US examination (121 LNs) and in 192 LNs (all
metastatic) in which microcalciﬁcations were not evident at US.
Two LNs positive at the BFI-TS and with calciﬁcations at US was
found to be a tuberculous nodes after treatment with intranodal
macrocalciﬁcations at histological examination. Strain index
greater than 1.5 was the best criterion in discrimination of meta-
static lymph nodes with 98.5% speciﬁcity, 84% sensitivity, and 93%
accuracy. We used a 5-pattern color scoring system based on dis-
tribution and percentage of stiff areas in the cervical lymph nodes.
The elastosonographic cut-off line for reactive versus metastatic
lymph nodes was set between patterns 2 and 3 while patterns 3e5
were considered metastatic.
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98%, 59% and 84% respectively; 83%, 100% and 89% for elastoso-
nography; and 92%, 94% and 93% for the combined evaluation. The
integrated use of elastosonography, B-ﬂow and gray-scale sonog-
raphy has the potential to improve the diagnosis of metastatic
enlarged cervical lymph nodes.
4. Discussion
The prevalence of nodular thyroid disease, detectable by ultra-
sound, is estimated at around 50%. However, only about 5% of the
nodules reveal malignant cyto histological diagnosis [11]. There-
fore, the differential diagnosis of nodules is crucial to allow the
early diagnosis of cancers and ensure appropriate treatment. In
thyroid cancer, there is no hint of a remodeling of the Ca2þ toolkit,
that has been observed in other malignancies, including renal
cellular carcinoma [13,14], and prostate cancer [15], mieloﬁbrosis
[16], and has been put forward as alternative target for selective
molecular therapies.
Currently, thyroid ultrasound is the ﬁrst-line examination for
the identiﬁcation and follow-up of nodules since it makes it
possible to formulate a suspicion of malignancy and select the
nodules to be subjected to FNAC [1,17e19]. Cytological evaluation is
considered the most accurate diagnostic technique. However, it has
two limitations: nondiagnostic results due to inadequate cytology
sampling and the presence of follicular proliferation or Hartle cells.
FNAC is also reserved for nodules with a maximum diameter
exceeding 10mm. Smaller nodules are not subjected to FNAC unless
they show suspicious ultrasonographic features and ﬂow. In the
case of follicular proliferation or in the presence of Hartle cells,
cytology does not differentiate adenoma from carcinoma, as the
differential diagnosis is based on the presence of capsular or
vascular invasion, which can only be evaluated histologically after
thyroidectomy [20e23]. B-ﬂow and elastosonography allows for
noninvasive, real-time tissue characterization which provides
additional information to B-mode and power Doppler ultrasound.
Although sonographic and Doppler features are the criteria taken
into consideration for FNAC performance and allow an accurate
identiﬁcation and follow-up of thyroid nodules, they do not
contribute signiﬁcantly to their characterization, which requires
cytological evaluation. On this basis, our study compared the in-
formation provided by B-ﬂow and RTE in addiction at ultrasound
with the cytological diagnosis achieved by FNAC in on a cohort of
patients with a sonographic diagnosis of thyroid nodules [24e27].
RTE technique made it possible to evaluate the mechanicaleelastic
properties of tissues, and in particular the stiffness of the nodules
analyzed. Stiffness was analyzed in terms of color map (SS) and by
comparison with the stiffness of the surrounding healthy paren-
chyma, by calculating the deformation ratio (SR). The results ob-
tained proved to be superior to those of conventional ultrasound. It
should be emphasized that Score 1 was found in benign lesions
only, with 98% NPV. This ﬁnding, if conﬁrmed in a larger study, may
exclude immediate recourse to FNAC, which would be reserved for
nodules showing a change in size or morphology over time. With
regard to the calculation of the SR, the signiﬁcant values reported in
recent studies were not reached [28,29] in discriminating benign
frommalignant forms. In agreement with the research published to
date, our study conﬁrmed that the beneﬁts of RTE are many:
 it is easy to perform, fast, accurate and reproducible;
 it provides a qualitative assessment of tissue elasticity in real
time;
 it provides a semiquantitative evaluation of the SR;
 it increases the sensitivity, speciﬁcity and NPV of conventional
ultrasound in the diagnosis of thyroid cancer; it can potentially help to select patients requiring invasive
diagnosis, thus lowering the costs for further investigations.
Fine punctuate calciﬁcations on sonography are generally
accepted as themost reliable indicators of malignancy because they
are related to PBs on microscopy.
Psammoma bodies are microcalciﬁed concentric laminated
structures commonly found in neoplasms such as meningioma,
papillary carcinoma of the ovary, and PTC [24,25]. The coalescence
of a number of PBs determines the formation of larger calciﬁcations
[24,25]. Psammoma bodies represent the remnants of necrotic
papillae; their diagnostic value [26,27] is greater if they are local-
ized within the cores of papillae and not in the neoplastic follicles
[26,30]. Up to now, the BFI technique has been used to evaluate
carotid artery stenosis and other vessel diseases [31,32]; our study
showed the importance of using this technique also during sono-
graphic diagnosis of thyroid nodules. Among echographic param-
eters, BFI twinkling sign pattern 3 had the highest degree of
sensitivity and speciﬁcity in the diagnosis of PTC; its PPV (96%) was
considerably higher than that of other B-mode and CFD features.
The most recent consensus statement by the Society of Radiologists
in Ultrasound stated that the presence of microcalciﬁcations within
the nodule raises the likelihood of malignancy, showing the highest
speciﬁcity but very low sensitivity [14]. In agreement with the
literature, our study showed that, in comparison to conventional
sonographic and CFD features, the sonographic detection of
microcalciﬁcations and PBs had the highest speciﬁcity level (95%) in
the diagnosis of thyroid cancer but low sensitivity (36%). The low
sensitivity of B-mode sonography for detection of micro-
calciﬁcations and PBs is due to its limited resolution power in
relation to the PB dimensions. The sensitivity of BFI twinkling sign
pattern 3 for detection of PBs was considerably higher than that of
B-mode imaging (65% versus 36%). Taking into account PTC only,
whose main characteristic is the presence of PBs, the sensitivity
was even higher (73%). In our opinion, pattern 3 does not reach
100% sensitivity levels for diagnosis of PTC for the following rea-
sons: (1) some PTC nodules have no PBs (or their number is
extremely limited); and (2) PBs go through a phase in which the
calcium component is poor or completely absent. The BFI twinkling
signmight lead to identiﬁcation of PB groupings whose dimensions
are considerably lower than those identiﬁed by the B-mode so-
nography. In our opinion, these results were achieved by means of
total inactivation of the 2-dimensional signal, which allowed a
relative increase of the signal produced by the aggregation of small
PBs. Because of the rough interface of sparse reﬂectors, PBs might
cause an irregular refraction of the ultrasound beam, simulating
movement, as well as a twinkling sign, which originates from uri-
nary stones in the color Doppler mode [30,33,34]. When compared
to a B-mode examination, speciﬁcity levels increase slightly (99%
versus 95%), due to the fact that the BFI twinkling sign allows
discrimination between the hyperechoic spots produced by
microcalciﬁcations and the ones produced by other factors
(colloidal crystals without the typical comet tail andmultiple tissue
or vascular interfaces). In our study, only 1 case proved to be pos-
itive for the BFI twinkling sign with pattern 3 and to have negative
FNA cytologic evaluation results. A follow-up will be conducted for
the following reasons: (1) a sampling mistake during FNA cytologic
evaluation might have taken place; and (2) microcarcinoma might
have developed on a benign nodule. In an analysis of our results, of
144 nodules with BFI twinkling sign pattern 2, none was PTC or
non-PTC cancer (PPV ¼ 0). We think that in these cases, the sign
was produced by the crystallized colloid, which with its multiple
interfaces, might have producedmultiple twinkling signs very close
to each other. Our hypothesis was supported by detection of
abundant colloid on the FNA cytologic evaluation in 83% of the
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considered a clear sign of benignity in the analyzed lesions. In
conclusion, our data support the use of the BFI technique as well as
the characterization of different twinkling sign patterns for accu-
rate evaluation of thyroid nodules. This technique increases the
sensitivity, speciﬁcity, PPV, and NPV levels but up to now has been
used only for evaluation of vascular structures; therefore, its po-
tentialities need to be clearly established. Further longitudinal
studies are necessary to conﬁrm our results for detection of thyroid
carcinoma. The BFI sign will play a key role in diagnosis and in the
standardization of sonographic examinations of thyroid nodules,
providing maximum speciﬁcity levels both in the case of benign
nodules with pattern 2 and in the case of malignant nodules with
pattern 3. We think that this new technique can overcome the
limits of traditional diagnostic sonography, for which research has
primarily focused on B-mode and color Doppler parameters, which
do not have a high degree of sensitivity and speciﬁcity at the same
time.
For the study of cervical lymph nodes neck US is highly sensitive
for the diagnosis of metastatic LNs. The speciﬁcity reported varies
from 85% to 90% [35]. A variety of diagnostic criteria have been
reported to be useful for the distinction between benign and
metastatic LNs. Lymph node shape has been used as a diagnostic
criterion of metastatic LNs. Metastatic lymph nodes often appeared
as round lesions, whereas benign nodes are usually ﬂat or oval [36].
In the present study, LN shape had an excellent speciﬁcity (90.8%)
but low sensitivity (52%). Initial or partial metastatic LN involve-
ment does not result in an alteration of the shape. Of note, LNs of
the parotid and submandibular regions are often round in normal
individuals [37]. The presence of a hyperechoic hilum of the nodes
is usually considered a strong diagnostic criterion for benign LNs
[38]. It has been reported that 84%e92% of benign nodes but less
than 5% of metastatic nodes have a hyperechoic hilum [39]. The
absence of a fatty hilum is often seen in normal individuals, espe-
cially in young subjects and in LNs located in level V [40]. In our
study, metastatic LNs with visible hilum and partial involvement
were at IeII level, whereas the LN metastases at low level showed
in 99.5% the absence of hyperechoic hilum. The absence of the hi-
lum had high sensitivity (91.9%) but low speciﬁcity (58.8%).
Differently, abnormal LN echogenicity had both high sensitivity and
speciﬁcity (resp., 81.9% and 85%). In our experience, echogenicity
was normal in 54 metastatic LNs (18%). Calciﬁcation was a speciﬁc
sign but not sensitive criterion. Calciﬁcation in metastatic LNs is
characteristic of PTC but generally rare. In our study, nodal calciﬁ-
cations were detected in only 93 of the 298 metastatic LNs. Simi-
larly, cystic appearance had a very high speciﬁcity (100%) and a low
sensitivity (21.1%). All LNs with hyperechoic punctuations or a
cystic appearance in a patient with PTC should be considered as
malignant. Assessment of nodal vascularity at color Doppler US is
another diagnostic criterion for metastatic LNs. It has been noted
that benign LNs tend to show hilar vascularity or to appear avas-
cular. In contrast, metastatic nodes tend to have peripheral or
mixed (both peripheral and hilar) vascularity. In our study, color
Doppler US vascularity had intermediate speciﬁcity (68.6%) but low
sensitivity (47.6%).These ﬁndings could reﬂect the high differenti-
ation of PTC and the reduced tendency to neoangiogenesis.
The BFI-TS had a higher speciﬁcity and sensitivity (resp.,99.7%
and 80.9%) than conventional US features. Given its high speciﬁcity
(99.7%), BFI-TS identiﬁes better suspicious LNs that should be re-
evaluated by surgery or US-guided FNAC. Therefore, the presence
of BFI in addition to conventional US increases the diagnostic
speciﬁcity for suspicious LNs. The techniques have several limits;
namely, they can be affected by the pulsatility of the main neck
vessel and by the deep places of examined LNs. These limits could
explain the missed detection of 57 LNs (19%) that were metastaticat histological examination. The other limit is the presence of
nonmetastatic LN calciﬁcations; in fact, the BFI-TS was false-
positive only in one LN with calciﬁcations deriving from tubercu-
losis. Overall, our results indicate that this technique can be applied
to studies of cervical nodes in patients with PTC and that its
sensitivity and speciﬁcity is higher than those of traditional US
diagnostic techniques.
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